NCT03397108 Assessing the Drug Exposure Risk of Infants Breastfed by Women With Inflammatory Bowel Disease Status COMPLETED Phase N/A
NCT03395184 Study To Evaluate The Efficacy And Safety Of Oral PF-06651600 And PF-06700841 In Subjects With Moderate To Severe Crohn's Disease Status COMPLETED Phase PHASE2
NCT03345849 A Study of the Efficacy and Safety of Upadacitinib in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional and/or Biologic Therapies Status COMPLETED Phase PHASE3
NCT03345836 A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Biologic Therapy Status COMPLETED Phase PHASE3
NCT03345823 A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn's Disease Who Completed the Studies M14-431 or M14-433 Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03283085 A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA) Status COMPLETED Phase PHASE3
NCT03279081 Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Participants With Crohn's Disease (CD) Status COMPLETED Phase PHASE3
NCT03257345 VEST: The UK Vedolizumab Real Life Experience Study in Inflammatory Bowel Disease Status UNKNOWN Phase N/A
NCT03256240 Study of the Kono-S Anastomosis Versus the Side-to-side Functional End Anastomosis Status RECRUITING Phase NA
NCT03251118 A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03234907 Vedolizumab Intravenous (IV) Compared to Placebo in Chinese Participants With Crohn's Disease. Status COMPLETED Phase PHASE3
NCT03223012 Impact of AbbVie Care Patient Support Program on Clinical, Health Economic and Patient Reported Outcomes, in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis and Axial Spondyloarthritis, in the Portuguese National Health Service Status COMPLETED Phase N/A
NCT03196427 Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) Status COMPLETED Phase PHASE2
NCT03167437 An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintenance Therapy With Ustekinumab Status RECRUITING Phase PHASE1/PHASE2
NCT03155945 Tolerability, Pharmacokinetics, and Efficacy of APD371 in Participants With Crohn's Disease Experiencing Abdominal Pain Status COMPLETED Phase PHASE2
NCT03138655 Vedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) Status COMPLETED Phase PHASE2
NCT03105128 A Study of the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease Status COMPLETED Phase PHASE3
NCT03105102 A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03104413 A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment Status COMPLETED Phase PHASE3